NEW Alzheimer Disease Antibodies -
Fully Characterized & Available for the first time from QED!
Four new Amyloid Beta monoclonal antibodies are now available from QED Bioscience. These antibodies to A1-42, Aβ1-40, and Aβ1-16 have been validated in multiple applications and are some of the best characterized Aβ antibodies available (learn more)
NEW FROM GENOVIS
FragIT™ Generate F(ab')2 and Fc fragments from 20-100mg of IgG in <30 minutes! (view)
Increased Demand for Anti-Ids
Evaluating pharmacokinetics or tissue distribution of therapeutic antibodies requires methods that distinguish an administered therapeutic antibody from endogenous immunoglobulins in patient samples. (learn more)
QED Bioscience has been designing and manufacturing antibodies for over 20 years, and throughout our history, our goals have remained unchanged: provide the best antibody products and services on the market and support our clients with the expertise and assistance they should expect from a full-spectrum antibody company like QED.
